Baumer (BALM4.SA) Stock Price

Baumer Price

CLOSED
15.90
​
Market closed

Revenue has compounded at 7.0% per year over the past 19 years to 194.00 M BRL. Earnings per share have grown at 11.0% per year over the last 19 years. Baumer's net margin stands at 16.5%, up from 10.5% several years earlier. Baumer currently offers a dividend yield of about 4.51%. The payout ratio is around 22% of earnings. The dividend has grown at 10.1% per year over the past 19 years.

Baumer stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baumer business model & stock analysis

Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets.

Frequently asked questions about Baumer

Converted at the current exchange rate, the Baumer share trades at 2.59 EUR (15.90 BRL).

The revenue cannot currently be calculated for Baumer.

The profit cannot currently be calculated for Baumer.

The P/E ratio cannot be calculated for Baumer at the moment.

The P/S cannot be calculated for Baumer currently.

The Eulerpool Quality Score for Baumer is 9/10.

The ISIN of Baumer is BRBALMACNPR2. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Baumer is BALM4.SA. The ticker symbol is used to trade Baumer shares on the stock exchange.

Fair ValueTerminal
14.31 BRL
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Brazil
Currency
BRL
Initial public offering
Jun 6, 1995
ISIN
BRBALMACNPR2
Cusip
P16211115
Market capitalization
155.82 M BRLMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
4.80
P/B Ratio
0.88
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
16.41 %
Dividend
Dividend yield
4.51 %
Payout Ratio
21.95 %
Dividend growth Ø5Y
2.13 %
Dividend payments per year
1
Dividend paid since
24 years
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
10.00 %
Last updated Nov 9, 2026, 3:45 AM

Baumer Peer Group

Baumer FIGI

BALM4:BZ · BBG000BFR771BALM4:BS · BBG000BFR7J8BALM4:BN · BBG000BFR8B4

All fundamentals and in-depth analysis of Baumer

Our stock analysis for Baumer stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Baumer. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.